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7
Clinical Characteristics DM1 (n=20) CTRL (n=19)
Age at sampling (average ± se) 40.9 ± 3.3 38.6 ± 1.1 (Table S2) (Table S3) .
Sex (male/female)
203
To narrow the list of candidates for validation, the ≈ 1.800 identified circRNAs were intersected 204 with a list of 29 circRNAs that were previously validated in human and mouse myoblasts [26], 205 resulting in 18 common circRNAs (Table S3) . Interestingly, most of them displayed a circular-to-206 linear ratio >0.5.
207
Validation by qPCR of differentially expressed circRNAs in DM1
208 skeletal muscles. (Table S4 ). All tested transcripts were confirmed to be readily expressed also in biceps brachii 224 biopsies, with the only exception of circMBNL1 (circMBNL1), showing an expression close to the 225 detection threshold. Five circRNAs, circASPH, circCDYL, circHIPK3, circRTN4_03 and 226 circZNF609, displayed a statistically significant increase following multiple comparison testing 227 (q<0.01) (Fig. S2 ).
228
To assess whether the observed induction of the circular transcripts was simply the consequence 229 of a general increase of transcription in the relevant genomic region in DM1 patients, modulation of 230 the ratios between the circular and the linear isoforms was calculated. We identified 4 circRNAs 231 (circCDYL, circHIPK3, circRTN4_03 and circZNF609) with a significantly increased, circular-to-232 linear ratio in DM1 muscles (Fig. 1a) , implying a de-regulation of the circular transcript 233 independent from its linear counterpart. Accordingly, a similar trend was also observed in the 12 234 RNAseq data, where the circular-to-linear ratios were higher in the DM1 affected muscles 235 compared to the controls (Table S3 ). 
DM1-circRNAs distinguish DM1 patients from controls.
247
To understand if the identified DM1-deregulated circRNAs (DM1-circRNAs) display a 248 discriminating power to identify DM1 patients, Receiver Operating Characteristic (ROC) curve 249 analysis was performed. Both, significantly increased circRNAs alone (Fig. S3 ) and circular-to-250 linear ratios (Fig. 2) were analyzed. Interestingly, with one exception (circCDYL), the 251 discrimination power between diseased and healthy individuals increased using the circular-to-252 linear ratios. In detail, among the five tested ratios, ZNF609 showed the largest area under the curve 253 (AUC= 0.92), while the others ranged between 0.84 and 0.86 (Fig. 2a) . Intriguingly, averaging all 254 five DM1-circRNA fractions into a "circular-to-linear score" (Fig. 2b) improved the performance 255 (AUC= 0.89) with respect to the singular fractions, with the exception of circZNF609, continuing to 256 show the largest AUC (Fig. 2a) .
257
In conclusion, each of the five circular-to-linear ratios, as well as the combined "circular-to-linear 258 score" of the DM1-circRNAs are useful to discriminate healthy form diseased patients. 269 patients is muscle strength, measured by the Medical Research Council (MRC) grading system. We 270 found that the changes of the circular fractions of circCDYL, circHIPK3, circRTN4_03 and 271 circZNF609 displayed a significant negative correlation to MRC (Fig. 3a) . Accordingly, a negative 272 correlation was observed also between the MRC grading and the circular-to-linear score (Fig. 3b) .
273 The strongest and most significant correlation was found for the circular fraction of ZNF609, with 274 Pearson r= 0.57 and p=0.0002.
275 Collectively, these data suggest a potential of circRNAs as DM1 biomarkers, in spite of the low 276 number of subjects analyzed. 
285
Since peripheral blood can be obtained with a minimally invasive procedure, it represents a 286 potentially interesting tissue for biomarker identification. Thus, we measured DM1-circRNA 287 expression in PBMCs and plasma of DM1 patients and sex-and age-matched controls. Diseased 288 and healthy subjects were chosen with the same criteria adopted for the harvesting of skeletal 289 muscle biopsies (Table S4) .
290
All DM1-circRNAs were readily detectable in PBMCs, but none of them showed a significant 291 modulation (Fig. S4) .
292
Among the DM1-circRNAs tested in plasma samples, circCDYL and circRTN4 were readily 293 detectable. A small, but not significant induction could be observed in DM1 patients for circCDYL 294 and circRTN4, consistent with the data obtained in biopsies (Fig. S5 ).
295
We conclude that the DM1-circRNA dysregulations observed in skeletal muscles are tissue 296 restricted.
297
DM1-circRNA expression in DM1 myogenic cell lines 298 We assessed whether circRNA alterations identified in DM1 muscle biopsies were also observed 
317
We also tested whether the silencing of CELF1, which is activated in patients and in DM1 disease 318 models [52], rescued DM1-circRNA expression in DM1 differentiated myogenic cells. In spite of 319 effective CELF1 knock-down (Fig. S8a) , no significant change of circZNF609, circRTN and 320 circRTN_03 levels was observed (Fig. S8b) .
321
We conclude that the DM1 myogenic cell lines studied reflect, at least in part, the outcome of the 322 DM1 biopsies and therefore represent a valuable tool for functional studies in vitro. 
338
During the testing phase of the bioinformatics pipeline with other data-sets, we performed several 339 attempts of differential expression analysis (data not shown). Unfortunately, performances obtained 340 were largely unsatisfactory, likely due to very low read numbers for most circRNA species and to 341 normalization difficulties. Therefore, in this study we chose another approach for the identification 342 of circRNAs potentially relevant in DM1. We filtered for circRNAs displaying expression across 343 many samples and then selected circRNAs previously shown to be involved in myogenesis [26] . Of 344 note, most of these circRNAs also displayed a high circular-to-linear ratio. This suggests that these 345 circRNAs are not a mere by-product of the transcript maturation process, and might also indicate an 346 independent regulation as well as an additional biological function.
347
For opportunity reasons, the validation step was performed in biceps brachii biopsies, since only 348 for this muscle type a sufficient number of samples was available to us. It should be acknowledged 349 that biceps brachii is generally less severely affected than other distal muscles in DM1 patients [1-350 3,39] . Thus, some of the circRNA level differences that failed to reach statistical significance in our 351 validation analysis, might be indeed relevant in distal muscles. On the other side, it is plausible to 352 hypothesize that circRNA alterations identified in proximal muscles could be more pronounced in 353 distal muscles.
